A 33-year-old woman in China facing a recurrent yolk sac tumor received a potentially life-saving treatment plan through a cross-border consultation between MD Anderson Cancer Center in the U.S. and PUMCH in Beijing. Facilitated by Medebound HEALTH, the collaboration resulted in a personalized recommendation for high-dose chemotherapy and stem cell transplantation, offering new hope for a rare and aggressive cancer.